When a company such as iShares Trust - iShares Biotechnology ETF splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.

Looking at the IBB split history from start to finish, an original position size of 1000 shares would have turned into 3000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into iShares Trust - iShares Biotechnology ETF shares, starting with a $10,000 purchase of IBB, presented on a split-history-adjusted basis factoring in the complete IBB split history.

About iShares Trust - iShares Biotechnology ETF

iShares Nasdaq Biotechnology Index Fund is an open-end management investment company. The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. As of Mar 31 2015, the Fund's total assets were $9,494,443,846 and the Fund's investment portfolio was valued at $9,486,288,900. According to our IBB split history records, iShares Trust - iShares Biotechnology ETF has had 1 split.

IBB Split History | www.SplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved